FOSUN HEALTH Logo

Breast Cancer Causes

catalogue

Breast Cancer Causes

Breast Cancer Causes

There is no single cause of breast cancer. What exists is a set of factors that shift the odds, some of them fixed and some of them not — and knowing which is which is what makes a risk conversation useful rather than frightening.

Age, and lifetime exposure to oestrogen

Age is the strongest single risk factor. Incidence rises steadily after the mid-forties and continues to rise, which is why screening programmes are organised around age rather than around symptoms. Being older is not a cause in itself; it is time during which the accumulated events that turn a cell malignant become more likely.

The second organising principle is oestrogen exposure. Breast tissue responds to oestrogen, and the total number of years breast cells are exposed to it is associated with risk — which is why the age at which periods began, the age at menopause and the number of pregnancies carried to term appear repeatedly in the literature.

Inherited risk: a minority of cases, the highest stakes

Around one case in ten is associated with an inherited predisposition, and the best-known of these involve BRCA1 and BRCA2 . A woman carrying a BRCA1 mutation faces a substantially elevated lifetime risk of breast cancer and also of ovarian cancer; the estimates vary by study and by family, which is why a genetic counsellor works with the actual mutation and family history rather than with a headline figure.

  • Other genes that matter

    TP53, PALB2, CHEK2, PTEN and STK11 are among the other genes associated with raised risk, each with its own pattern and its own surveillance implications. Multi-gene panel testing is now standard where testing is indicated, because testing only BRCA1 and BRCA2 will miss a proportion of families with a real inherited cause.

  • When testing is worth doing

    Testing is indicated for patients with triple-negative breast cancer diagnosed young, with bilateral disease, with breast and ovarian cancer in the same person, with male breast cancer, or with a strong family history across generations. Where a mutation is found, the result changes surveillance for the patient and is testable for relatives.

  • Family history without a mutation

    Most women with a family history do not carry an identifiable mutation, and their risk is still meaningfully higher than average. A first-degree relative with breast cancer roughly doubles the risk; two affected relatives raise it further; cancer in a male relative or ovarian cancer at any age in the family are additional signals. This group is managed with earlier and more frequent imaging.

  • What a normal test does not mean

    A negative panel does not remove risk, because only known genes are examined. For a family with a strong pattern and no finding, surveillance is still arranged on the basis of the family history itself.

Reproductive history and hormonal treatments

These factors describe how long breast tissue has been exposed to endogenous hormones. They describe populations, not individuals — which is why they are frequently misunderstood.

Factor Direction of risk Practical implication
Menopause after 55 Higher Nothing to be done about it; contributes to the case for regular screening
First period before 12 Higher Increases the value of screening from the recommended starting age
First birth after 30, or no pregnancy Higher A modest effect at population level; not a reason to alter family plans
Breastfeeding Slightly lower One of the few reproductive factors that moves risk in a favourable direction
Combined hormone replacement therapy Higher with prolonged use Discussed case by case with the prescribing doctor; short-term use for severe symptoms is a different calculation
Oral contraceptive use Slightly higher while in use The effect is small and declines after stopping

Directions of effect follow international guideline consensus; the size of any individual effect is small relative to age and inherited risk.

What can actually be changed

This is the part of the page that matters most, because it is the only part anyone can act on. None of these factors is a guarantee, and none of them means that a person who develops breast cancer did something wrong.

  • Alcohol

    Alcohol consumption is associated with higher breast cancer risk, and the association appears even at relatively low intakes, with risk rising as consumption rises. Reducing intake — rather than substituting one drink for another — is one of the clearest modifiable steps available.

  • Body weight after menopause

    Higher body weight after menopause is associated with higher risk, because fat tissue is a source of oestrogen. Before menopause the relationship is less consistent. Regular physical activity is associated with lower risk independently of weight.

  • Physical activity

    Moderate activity — the kind that raises the heart rate for a sustained period, several times a week — is associated with lower risk. The effect is modest, and it is one of the few interventions with no downside worth weighing.

A caution about how this information is used. These factors shift probabilities across populations. They do not explain any individual case, and a woman who develops breast cancer has not caused it. Genetic risk, age and chance account for far more than lifestyle does, and the purpose of knowing the modifiable factors is to have something to act on — not to assign responsibility.

Breast density, and why it is reported

Dense breast tissue — proportionally more glandular and fibrous tissue, less fat — is a modest independent risk factor, and it has a second consequence that matters more practically: on a mammogram, dense tissue and tumour both appear white, which reduces the test's sensitivity. Density is therefore reported alongside mammography results, and ultrasound is added for women with dense breasts. It is largely inherited and changes with age and hormonal status. It is worth knowing your own density category, because it determines whether mammography alone is adequate for you.

Benign breast disease and previous treatment

Not all raised risk comes from cancer history. Certain benign findings carry a modest increase, and previous radiotherapy to the chest carries a substantial one.

  • Benign findings that raise risk

    Atypical ductal or lobular hyperplasia, and lobular carcinoma in situ, are associated with a higher risk of later invasive cancer and often prompt more frequent surveillance, and in some cases risk-reducing endocrine therapy. Ordinary fibrocystic change and simple cysts do not carry this implication.

  • Previous chest radiotherapy

    Radiotherapy to the chest during childhood or early adulthood — for example as treatment for Hodgkin lymphoma — substantially raises the lifetime risk of breast cancer. Screening for these patients begins much earlier than usual and generally includes MRI alongside mammography, on a schedule set by a specialist.

Male breast cancer

Breast cancer in men is uncommon but real, and it is usually diagnosed later than in women because neither the patient nor the first clinician expects it. The presentation is typically a firm lump behind the nipple, sometimes with nipple discharge or skin change.

Risk is strongly associated with BRCA2 mutations in particular, with a family history of breast cancer, with conditions that alter the oestrogen-to-androgen balance, and with previous chest radiotherapy. Because a male breast is small, tumours reach the skin and chest wall early, and treatment usually involves mastectomy. Endocrine therapy follows the receptor status exactly as in women, and men with a hormone receptor-positive tumour are usually treated with tamoxifen.

Things that are not risk factors

Several widely repeated claims have no good evidence behind them, and clearing them up frees attention for the factors that do matter.

  • Not supported by evidence

    Antiperspirants and deodorants; underwire bras; breast implants placed for cosmetic reasons; abortion; and stress as a direct cause. Studies large enough to detect a real effect have not found one for any of these.

  • Worth distinguishing carefully

    Breast injury does not cause breast cancer, but it can draw attention to a lump that was already there. A lump appearing after trauma should still be imaged rather than attributed to the trauma itself.

What to do with this information

Risk factors are most useful when they turn into a specific plan. For most women that means knowing the age at which to begin screening and whether mammography alone is enough. For some it means genetic testing, or earlier imaging, or a discussion about risk-reducing options.

If a relative has been diagnosed, her receptor and genetic results are relevant to your own assessment, and it is worth asking for them. The prevention and screening page sets out what those plans look like in practice, and symptoms and early warning signs covers what to do if something has already changed.

Frequently Asked Questions

Does a family history mean I will get breast cancer?

No. Most women with an affected relative never develop the disease, and most women who do develop it have no family history at all. A first-degree relative with breast cancer approximately doubles the risk, which sounds alarming but means the great majority of women in that situation still will not develop it. What a family history changes is the surveillance plan — earlier and more frequent imaging — and it may justify genetic testing. It does not mean the outcome is fixed.

Should I be tested for BRCA1 and BRCA2?

Testing is worth discussing if you have triple-negative breast cancer diagnosed at a young age, bilateral breast cancer, both breast and ovarian cancer, breast cancer as a man, or a family pattern including breast cancer at young ages, ovarian cancer, or male breast cancer. Genetic counselling comes first, because the result has implications for relatives as well as for you, and because a negative result in the absence of a known family mutation is harder to interpret. Where a mutation is found, surveillance and risk-reducing options change accordingly.

Can I reduce my risk by changing my lifestyle?

Partly, and it is worth being honest about the size of the effect. Limiting alcohol, maintaining a healthy body weight after menopause and staying physically active are all associated with lower risk, and none of them guarantees anything. They are worth doing because the direction is favourable and the other benefits are real — not because they remove the need for screening. Nothing in the lifestyle group matches the effect of age or of an inherited mutation.

I had a benign biopsy years ago. Does that matter now?

It depends on what the biopsy showed. Atypical ductal hyperplasia, atypical lobular hyperplasia and lobular carcinoma in situ are associated with a higher risk of later invasive cancer and usually mean more frequent surveillance, and in some cases a discussion about risk-reducing endocrine therapy. Ordinary fibrocystic changes, simple cysts and uncomplicated fibroadenomas do not carry that implication. The pathology report from that biopsy is worth obtaining rather than relying on a summary of it.

Patient Stories

Stories from our breast cancer programme, pulled automatically from the patient story library by disease tag.

View all patient stories →

Want your personal risk assessed?

Send your family history, any genetic test results, previous breast imaging and pathology reports. Our breast team will return a written assessment of your risk profile and a recommended surveillance plan within 48 hours of the file being complete — with the option of genetic counselling where it is indicated.

Want to see the whole process first? Your full medical journey, step by step →

Book an Appointment Request a Video Consultation

WhatsApp +86 172-7459-8280 · EN / 中文 · 24h within business hours

Follow Fosun Health

Apply for an Appointment

Do you have test results*